Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease (Q35094913)
scientific article
Language:
Current Data About Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease
(P31) (Q13442814)
(P248)
(P698) 12666106
(P813) Sunday, August 6, 2017

(P50) (Q66915960)
(P1545) 1
(P1932) Anthony H V Schapira
(P248)
(P698) 12666106
(P813) Sunday, August 6, 2017

(Q66933446)
(P1545) 2
(P1932) C Warren Olanow
(P248)
(P698) 12666106
(P813) Sunday, August 6, 2017

(P304) S149-57; discussion S157-9
(P248)
(P698) 12666106
(P813) Sunday, August 6, 2017

(P407) (Q1860)

(P478) 53 Suppl 3
(P248)
(P698) 12666106
(P813) Sunday, August 6, 2017

(P577) Wednesday, January 1, 2003
(P248)
(P698) 12666106
(P813) Sunday, August 6, 2017

(P921) (Q11085)
(P887)

(P1433) (Q564414)
(P248)
(P698) 12666106
(P813) Sunday, August 6, 2017

(P1476) "Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease" (language: en)
(P248)
(P698) 12666106
(P813) Sunday, August 6, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article

External Links
(P356) 10.1002/ANA.10514
(P698) 12666106